ArticleThe Journal of general virology2021

Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.

Marie O Pohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.